ISAL 2023 | Validation of 2022 diagnostic & prognostic classifications of AML
Enrico Attardi
• 21 Mar 2023
Enrico Attardi, MD, University of Rome Tor Vergata, Rome, Italy, shares the findings of a real-world study investigating the applicability of the recently published diagnostic classifications of acute myeloid leukemia (AML) by the ICC and WHO, as well as the updated prognostic classification of AML by the European LeukemiaNet (ELN). This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
